RegenxBio regenxbio.com


Public list: BIO 2016 (619) Pharma Startups (4729)

RegenxBio is focused on the effort to translate the latest gene delivery research into therapeutic applications for diseases where there is serious unmet need. The company is developing novel therapeutics and research tools based on rAAV (recombinant adeno-associated) vectors. ReGenX's NAV Technology offers a platform for safer, highly efficient and specific expression of biologics with therapeutic effect.

RegenxBio is focused on the effort to translate the latest gene delivery research into therapeutic applications for diseases where there is serious unmet need. The company is developing novel therapeutics and research tools based on rAAV (recombinant...Show all

Company (IPO / Went public)

Phone: 240-552-8181

Fax:

9712 Medical Center Drive

Rockville, 20850
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
RegenxBio $249.8M Sep 17, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related RegenxBio Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 18 investors
There is no Competitors data available for this company. Please select another tab.

Patents